Draig Therapeutics

Draig Therapeutics is a psychiatric medicines biotech developing AMPA/GABA-targeted treatments for depression and other psychiatric conditions. The company raised a $65 million Series B led by Deep Track Capital, with participation from Janus Henderson Investors, Marshall Wace, British Business Bank, and Jefferson Life Sciences.